Osteoarthritis and inflammation: a serious disease with overlapping phenotypic patterns
Francis Berenbaum1, Chris Walker2
1INSERM CRSA, Department of Rheumatology, Hospital Saint Antoine, AP-HP.Sorbonne Université , Paris, France.
Postgraduate Medicine
|February 27, 2020
Summary
Osteoarthritis (OA) is a prevalent joint disease causing disability and economic burden. Understanding OA phenotypes like post-trauma, metabolic, and aging is key to improving patient treatment outcomes.
Area of Science:
- Rheumatology
- Orthopedics
- Geriatrics
Background:
- Osteoarthritis (OA) is the most common arthritic condition in individuals over 60, significantly impacting disability and healthcare costs.
- Pain is a primary symptom and leading cause of disability in OA patients.
- OA is now recognized as a complex disease affecting the entire joint, not just cartilage, with evolving understanding of its pathophysiology.
Purpose of the Study:
- To review the current understanding of osteoarthritis (OA).
- To focus on three key OA phenotypes: post-trauma, metabolic, and aging.
- To highlight the importance of understanding OA phenotypes for improved treatment.
Main Methods:
- Literature review of osteoarthritis (OA) pathophysiology and phenotypes.
- Analysis of OA's impact on disability, comorbidity, and mortality.
- Synthesis of current research on OA disease mechanisms and patient stratification.
Main Results:
- OA is increasingly recognized as a serious disease due to its significant impact.
- The pathophysiology of OA involves multiple joint tissues and can be described by overlapping phenotypes.
- Key phenotypes include post-trauma, metabolic, and aging-related OA.
Conclusions:
- A deeper understanding of OA phenotypes, especially early in the disease, is crucial for enhancing treatment efficacy.
- Future treatments for OA may be personalized based on a patient's specific phenotype and disease pathway.
- Tailoring non-pharmacological and pharmacological interventions to individual OA phenotypes holds promise for better patient outcomes.
Related Concept Videos
The JAK-STAT Signaling Pathway
11.6K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
11.6K
Inflammation
61.2K
Overview
61.2K
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
367
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
367
COPD: Pathogenesis and Clinical Features
1.7K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.7K
Inflammatory Bowel Disease II: Crohn's Disease
850
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
850
Chronic Bowel Disorders: Introduction
699
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
699


